Literature DB >> 30630644

Re: Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Carcinoma (PURE-01): An Open-label, Single-arm, Phase II Study.

Kilian M Gust1, Shahrokh F Shariat2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30630644     DOI： 10.1016/j.eururo.2018.12.034

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  2 in total

1.  Second line immune checkpoint inhibition in urothelial cancer.

Authors:  Kilian M Gust; Mohammad Abufaraj; David D'Andrea; Marco Moschini; Francesco Soria; Shahrokh F Shariat
Journal:  Transl Androl Urol       Date:  2019-10

Review 2.  Trial watch: IDO inhibitors in cancer therapy.

Authors:  Julie Le Naour; Lorenzo Galluzzi; Laurence Zitvogel; Guido Kroemer; Erika Vacchelli
Journal:  Oncoimmunology       Date:  2020-06-14       Impact factor: 8.110
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.